[go: up one dir, main page]

DK0864329T3 - Medicinsk præparat, som indeholder en lipofil ædelgas - Google Patents

Medicinsk præparat, som indeholder en lipofil ædelgas

Info

Publication number
DK0864329T3
DK0864329T3 DK97113757T DK97113757T DK0864329T3 DK 0864329 T3 DK0864329 T3 DK 0864329T3 DK 97113757 T DK97113757 T DK 97113757T DK 97113757 T DK97113757 T DK 97113757T DK 0864329 T3 DK0864329 T3 DK 0864329T3
Authority
DK
Denmark
Prior art keywords
preparation containing
noble gas
medical preparation
lipophilic
lipophilic noble
Prior art date
Application number
DK97113757T
Other languages
English (en)
Inventor
Michael Georgieff
Original Assignee
Michael Georgieff
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Michael Georgieff filed Critical Michael Georgieff
Application granted granted Critical
Publication of DK0864329T3 publication Critical patent/DK0864329T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0026—Blood substitute; Oxygen transporting formulations; Plasma extender
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0029—Parenteral nutrition; Parenteral nutrition compositions as drug carriers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A61P23/02—Local anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M16/00—Devices for influencing the respiratory system of patients by gas treatment, e.g. ventilators; Tracheal tubes
    • A61M16/08—Bellows; Connecting tubes ; Water traps; Patient circuits
    • A61M16/0816—Joints or connectors
    • A61M16/0841—Joints or connectors for sampling
    • A61M16/085—Gas sampling
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2230/00—Measuring parameters of the user
    • A61M2230/40—Respiratory characteristics
    • A61M2230/43—Composition of exhalation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2230/00—Measuring parameters of the user
    • A61M2230/40—Respiratory characteristics
    • A61M2230/43—Composition of exhalation
    • A61M2230/437—Composition of exhalation the anaesthetic agent concentration

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Anesthesiology (AREA)
  • Biomedical Technology (AREA)
  • Dermatology (AREA)
  • Neurosurgery (AREA)
  • Inorganic Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Nutrition Science (AREA)
  • Hematology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK97113757T 1997-03-10 1997-08-08 Medicinsk præparat, som indeholder en lipofil ædelgas DK0864329T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19709704A DE19709704C2 (de) 1997-03-10 1997-03-10 Verwendung einer flüssigen Präparation von Xenon zur intravenösen Verabreichung bei Einleitung und/oder Aufrechterhaltung der Anaesthesie

Publications (1)

Publication Number Publication Date
DK0864329T3 true DK0864329T3 (da) 2001-04-09

Family

ID=7822782

Family Applications (2)

Application Number Title Priority Date Filing Date
DK97113757T DK0864329T3 (da) 1997-03-10 1997-08-08 Medicinsk præparat, som indeholder en lipofil ædelgas
DK98913672T DK0966291T3 (da) 1997-03-10 1998-03-06 Medicinsk præparat, som indeholder en lipofil ædelgas

Family Applications After (1)

Application Number Title Priority Date Filing Date
DK98913672T DK0966291T3 (da) 1997-03-10 1998-03-06 Medicinsk præparat, som indeholder en lipofil ædelgas

Country Status (33)

Country Link
US (3) US6197323B1 (da)
EP (3) EP0864329B1 (da)
JP (1) JPH10251142A (da)
KR (2) KR100504287B1 (da)
CN (1) CN1104901C (da)
AP (1) AP1162A (da)
AT (3) ATE198047T1 (da)
AU (1) AU738946C (da)
BG (1) BG64583B1 (da)
BR (1) BR9808227A (da)
CA (1) CA2283227A1 (da)
CZ (1) CZ292767B6 (da)
DE (4) DE19709704C2 (da)
DK (2) DK0864329T3 (da)
EE (1) EE03807B1 (da)
ES (2) ES2152608T3 (da)
GR (1) GR3035553T3 (da)
HK (1) HK1028335A1 (da)
HU (1) HU224985B1 (da)
ID (1) ID23151A (da)
IL (1) IL131557A (da)
NO (1) NO994091L (da)
NZ (1) NZ337534A (da)
OA (1) OA11156A (da)
PL (1) PL189841B1 (da)
PT (2) PT864329E (da)
RU (1) RU2204397C2 (da)
SI (1) SI0966291T1 (da)
SK (1) SK284249B6 (da)
TR (1) TR199902205T2 (da)
TW (2) TWI241914B (da)
WO (2) WO1998040083A1 (da)
ZA (2) ZA981958B (da)

Families Citing this family (86)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19709704C2 (de) * 1997-03-10 1999-11-04 Michael Georgieff Verwendung einer flüssigen Präparation von Xenon zur intravenösen Verabreichung bei Einleitung und/oder Aufrechterhaltung der Anaesthesie
US6979456B1 (en) 1998-04-01 2005-12-27 Jagotec Ag Anticancer compositions
AU750050B2 (en) * 1998-06-03 2002-07-11 Scott Laboratories, Inc. Apparatus and method for providing a conscious patient relief from pain and anxiety associated with medical or surgical procedures
DE19833014A1 (de) * 1998-07-23 2000-01-27 Messer Griesheim Gmbh Edelgashaltige Injektionsanästhesiemittel
KR100777647B1 (ko) * 1998-08-19 2007-11-19 스키에파마 캐나다 인코포레이티드 프로포폴의 수용성 주사용 분산액
DE19851605A1 (de) * 1998-11-09 2000-05-11 Messer Griesheim Gmbh Mikropartikel enthaltendes Injektionsanästhesiemittel
DE19851604A1 (de) * 1998-11-09 2000-05-11 Messer Griesheim Gmbh Injektionsanästhesiemittel mit hydrophiler Phase
DE19852472A1 (de) * 1998-11-13 2000-05-25 Messer Griesheim Gmbh Analyse von mit Gasen beladenen Flüssigkeiten
DE19910986C2 (de) 1999-03-11 2001-06-07 Aga Ab Verwendung von Xenon bei der Behandlung von Neurointoxikationen
GB9913677D0 (en) * 1999-06-11 1999-08-11 Imperial College Formulation
AU5985900A (en) * 1999-07-19 2001-02-05 Michael Georgieff Novel spinal and epidural anaesthetic
US6653354B2 (en) 1999-07-29 2003-11-25 Protexeon Limited NMDA antagonist comprising xenon
GB9917822D0 (en) * 1999-07-29 1999-09-29 Imperial College Nmda antagonist
US20020177232A1 (en) * 2001-05-23 2002-11-28 Melker Richard J. Method and apparatus for detecting illicit substances
JP4773019B2 (ja) 1999-11-08 2011-09-14 ユニバーシティ オブ フロリダ リサーチ ファンデーション インコーポレーティッド 薬物の服薬遵守を監視するためのマーカー検出の方法および器具
US20050037374A1 (en) * 1999-11-08 2005-02-17 Melker Richard J. Combined nanotechnology and sensor technologies for simultaneous diagnosis and treatment
US20050233459A1 (en) * 2003-11-26 2005-10-20 Melker Richard J Marker detection method and apparatus to monitor drug compliance
US6623765B1 (en) * 2000-08-01 2003-09-23 University Of Florida, Research Foundation, Incorporated Microemulsion and micelle systems for solubilizing drugs
FR2812545B1 (fr) * 2000-08-03 2003-03-28 Air Liquide Sante Int Aerosol medicamenteux inhalable dans le traitement ou la prevention de la douceur
DE10045845A1 (de) * 2000-09-14 2002-04-04 Messer Griesheim Gmbh Xenon als Arzneimittel
TW523409B (en) * 2000-09-15 2003-03-11 Baxter Int Container for inhalation anesthetic
US7104963B2 (en) * 2002-01-22 2006-09-12 University Of Florida Research Foundation, Inc. Method and apparatus for monitoring intravenous (IV) drug concentration using exhaled breath
US6981947B2 (en) 2002-01-22 2006-01-03 University Of Florida Research Foundation, Inc. Method and apparatus for monitoring respiratory gases during anesthesia
AU2002220881A1 (en) * 2000-12-04 2002-06-18 Uws Ventures Limited Noble gas complexes
US7052854B2 (en) 2001-05-23 2006-05-30 University Of Florida Research Foundation, Inc. Application of nanotechnology and sensor technologies for ex-vivo diagnostics
US7052468B2 (en) 2001-05-24 2006-05-30 University Of Florida Research Foundation, Inc. Method and apparatus for detecting environmental smoke exposure
DE10141650C1 (de) 2001-08-24 2002-11-28 Lohmann Therapie Syst Lts Transdermales Therapeutisches System mit Fentanyl bzw. verwandten Substanzen
MXPA04004246A (es) * 2001-11-01 2004-09-10 Scott Lab Inc Interfaz de usuario para sistemas y metodos de suministro de sedacion y analgesia.
US20070167853A1 (en) * 2002-01-22 2007-07-19 Melker Richard J System and method for monitoring health using exhaled breath
DE10205056A1 (de) * 2002-02-07 2003-08-14 Hartwin Hobler Gesteuerte Mischung von Fluids für medizinische und biologische Anwendungen
GB0209998D0 (en) * 2002-05-01 2002-06-12 Protexeon Ltd Use
MXPA04011423A (es) * 2002-05-16 2005-02-17 Scott Laborotories Inc Equipos de suministros medicos para la sedacion y analgesia.
US20040022842A1 (en) * 2002-06-03 2004-02-05 Mebiopharm Co., Ltd. Liposome preparations containing oxaliplatin
DE50311092D1 (de) 2002-06-12 2009-03-05 Air Liquide Deutschland Gmbh Cerebrale protektion mit einem xenonhaltigen gas
DE10327000A1 (de) * 2002-06-12 2003-12-24 Messer Griesheim Gmbh Xenonhaltiges Spasmolytikum
US20050255169A1 (en) * 2002-07-05 2005-11-17 Messer Griesheim Adjuvant containing xenon
GB0218153D0 (en) * 2002-08-05 2002-09-11 Ic Innovations Ltd An analgesic agent for newborn or retal subjects
WO2004030525A2 (en) * 2002-10-03 2004-04-15 Scott Laboratories, Inc. Systems and methods for providing trend analysis in a sedation and analgesia system
US20060160134A1 (en) * 2002-10-21 2006-07-20 Melker Richard J Novel application of biosensors for diagnosis and treatment of disease
AU2003288214A1 (en) * 2002-12-06 2004-06-30 Michael Georgieff Nasal pharmaceutical preparation containing an active lipophilic liquid or gaseous ingredient
ATE526876T1 (de) * 2003-01-23 2011-10-15 Univ Florida Verfahren und gerät zur überwachung der intravenösen konzentration von medikamenten mittels ausatemluft
ATE380554T1 (de) * 2003-10-10 2007-12-15 Protexeon Ltd Verwendung von xenon mit hypothermie zur behandlung von neugeborenen-asphyxie
US20080031971A1 (en) * 2003-10-21 2008-02-07 Aga Ab Use Of Xenon For The Prevention Of Programmed Cell Death
US20050191757A1 (en) * 2004-01-20 2005-09-01 Melker Richard J. Method and apparatus for detecting humans and human remains
US20060062734A1 (en) * 2004-09-20 2006-03-23 Melker Richard J Methods and systems for preventing diversion of prescription drugs
JP2006248978A (ja) * 2005-03-10 2006-09-21 Mebiopharm Co Ltd 新規なリポソーム製剤
US20060257883A1 (en) * 2005-05-10 2006-11-16 Bjoraker David G Detection and measurement of hematological parameters characterizing cellular blood components
US7914460B2 (en) 2006-08-15 2011-03-29 University Of Florida Research Foundation, Inc. Condensate glucose analyzer
CA2712516C (en) 2008-01-22 2016-06-28 Vapogenix, Inc. Volatile anesthetic compositions and methods of use
AU2014277860A1 (en) * 2008-01-22 2015-01-22 Board Of Regents, The University Of Texas System Volatile anesthetic compositions and methods of use
WO2010033439A2 (en) * 2008-09-17 2010-03-25 The Brigham And Women's Hospital, Inc. Anesthesia simulator and controller for closed-loop anesthesia
EP2427243A4 (en) * 2009-05-05 2012-11-21 Vapogenix Inc NEW FORMULATIONS OF VOLATILE ANESTHETICS AND METHOD OF ADMINISTRATION
US9278048B2 (en) 2009-05-06 2016-03-08 Baxter International, Inc. Pharmaceutical product and method of use
US10045996B2 (en) 2010-03-17 2018-08-14 Novaliq Gmbh Pharmaceutical composition for treatment of increased intraocular pressure
CN101961051A (zh) * 2010-09-08 2011-02-02 营口艾特科技有限公司 含氙气的液体及其制备方法
CN101928636B (zh) * 2010-09-08 2012-11-14 营口艾特科技有限公司 含氙气的油脂类液体及其制备方法
CN101940538B (zh) * 2010-09-08 2012-07-04 营口艾特科技有限公司 含氙气的化妆品及其制备方法
EP2444063A1 (en) 2010-10-20 2012-04-25 Novaliq GmbH Liquid pharmaceutical compositions for the delivery of active ingredients
EP2462921A1 (en) 2010-11-11 2012-06-13 Novaliq GmbH Liquid pharmaceutical compositions for the treatment of a posterior eye disease
JP6073244B2 (ja) * 2011-01-04 2017-02-01 ノバリック ゲーエムベーハー 部分フッ素化アルカンを含むｏ／ｗエマルション
CN103596554A (zh) 2011-05-25 2014-02-19 诺瓦利克有限责任公司 基于半氟化烷烃类的外用药物组合物
RU2475249C1 (ru) * 2011-10-05 2013-02-20 Учреждение Российской академии медицинских наук Научно-исследовательский институт фармакологии Сибирского отделения РАМН Средство для наружной терапии хронических рецидивирующих воспалительных заболеваний кожи
CA2862974C (en) 2012-01-23 2021-11-16 Novaliq Gmbh Stabilised protein compositions based on semifluorinated alkanes
DE102012203897B4 (de) 2012-03-13 2014-11-27 Kist Europe Forschungsgesellschaft Mbh Vorrichtung zur Durchführung einer Anästhesie oder Analgosedierung und Verfahren zum Betreiben einer Vorrichtung zur Durchführung einer Anästhesie oder Analgosedierung
CN110464709A (zh) 2012-08-10 2019-11-19 德克萨斯州大学系统董事会 用于治疗中风的神经保护性脂质体组合物和方法
DK2895144T3 (da) 2012-09-12 2017-03-06 Novaliq Gmbh Semifluorede alkansammensætninger
CN104619314B (zh) 2012-09-12 2017-09-22 诺瓦利克有限责任公司 包含半氟化烷烃的混合物的组合物
CN105228591B (zh) * 2013-03-15 2019-08-13 德克萨斯州大学系统董事会 富含稀有气体的液体及其制备和使用方法
KR101545706B1 (ko) * 2013-05-10 2015-08-26 주식회사 아미팜 포스파티딜콜린을 포함하는 지방 분해용 조성물 및 이의 제조방법
CA2918419C (en) 2013-07-23 2022-05-03 Novaliq Gmbh Stabilized antibody compositions
US20150328073A1 (en) * 2014-05-19 2015-11-19 Joseph Gerard Archer Hyperbaric Social Establishment or Residence
US10499838B2 (en) * 2015-04-24 2019-12-10 Drexel University Non-invasive brain water monitoring device for cerebral edema and cerebral autoregulation monitoring system and method
US20170087100A1 (en) 2015-09-30 2017-03-30 Novaliq Gmbh Semifluorinated compounds and their compositions
CN113662928A (zh) 2015-09-30 2021-11-19 诺瓦利克有限责任公司 用于眼部给药的半氟化化合物
EP3442480B1 (en) 2016-06-23 2019-10-02 Novaliq GmbH Topical administration method
WO2018054932A1 (en) 2016-09-22 2018-03-29 Novaliq Gmbh Pharmaceutical compositions for use in the therapy of blepharitis
ES2965677T3 (es) 2016-09-23 2024-04-16 Novaliq Gmbh Composiciones oftálmicas que comprenden ciclosporina
BR112019021917A8 (pt) 2017-04-21 2023-03-21 Novaliq Gmbh Composições de iodo
US11278503B2 (en) 2017-05-12 2022-03-22 Novaliq Gmbh Pharmaceutical compositions comprising semifluorinated alkanes for the treatment of contact lense-related conditions
MX2020003534A (es) 2017-09-27 2020-07-29 Novaliq Gmbh Composiciones oftalmicas que comprenden latanoprost para usarse en el tratamiento de las enfermedades oculares.
WO2019068763A1 (en) 2017-10-04 2019-04-11 Novaliq Gmbh OPHTHALMIC COMPOSITIONS COMPRISING F6H8
BR112020017838A2 (pt) 2018-03-02 2020-12-22 Novaliq Gmbh Composições farmacêuticas que compreendem nebivolol
EP3784246A1 (en) 2018-04-27 2021-03-03 Novaliq GmbH Ophthalmic compositions comprising tafluprost for the treatment of glaucoma
SG11202102820VA (en) 2018-10-12 2021-04-29 Novaliq Gmbh Ophthalmic composition for treatment of dry eye disease
JP2022512230A (ja) * 2018-12-14 2022-02-02 ペア セラピューティクス インコーポレイテッド ブプレノルフィン含有製品の誘導を最適化するためのデジタル治療構成要素
EP3839959A1 (en) * 2019-12-19 2021-06-23 Koninklijke Philips N.V. Transdermal sedative release control in autonomous imaging

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL139241B (nl) * 1967-01-09 Mallinckrodt Chemical Works Werkwijze voor het bereiden en afvoeren van een farmaceutisch aanvaardbare, een radioactief gas bevattende zoutoplossing, alsmede gevulde eenheidspatroon verkregen door toepassing van deze werkwijze.
GB1472793A (en) * 1974-03-28 1977-05-04 Ici Ltd Pharmaceutical compositions
GR64915B (en) * 1978-09-14 1980-06-09 Janssen Pharmaceutica Nv Improved etomidate-containing compositions
US4725442A (en) * 1983-06-17 1988-02-16 Haynes Duncan H Microdroplets of water-insoluble drugs and injectable formulations containing same
US4622219A (en) * 1983-06-17 1986-11-11 Haynes Duncan H Method of inducing local anesthesia using microdroplets of a general anesthetic
US5140981A (en) 1986-11-24 1992-08-25 Picker International, Inc. End-tidal gas detection
SE8700977D0 (sv) * 1987-03-09 1987-03-09 Olof Werner Enhet som i olika grad separerar gasinnehallet i drivkrets och mottagarkrets, men som enda tillater gasgenomslepp i bada riktningarna (oppen separation)
US4781698A (en) * 1987-04-09 1988-11-01 Parren Mark L Selectable drop size infusion metering device
DE3712598A1 (de) * 1987-04-14 1988-10-27 Siemens Ag Inhalations-anaesthesiegeraet
DE3828905A1 (de) * 1988-08-23 1990-03-15 Schering Ag Mittel bestehend aus cavitate oder clathrate bildenden wirt/gast-komplexen als kontrastmittel
DE3940389A1 (de) * 1989-12-06 1991-06-13 Abolghassem Prof Dr M Pakdaman Therapeutisches mittel
US5334381A (en) 1989-12-22 1994-08-02 Unger Evan C Liposomes as contrast agents for ultrasonic imaging and methods for preparing the same
US5088499A (en) * 1989-12-22 1992-02-18 Unger Evan C Liposomes as contrast agents for ultrasonic imaging and methods for preparing the same
US5585112A (en) * 1989-12-22 1996-12-17 Imarx Pharmaceutical Corp. Method of preparing gas and gaseous precursor-filled microspheres
US5320093A (en) 1990-12-21 1994-06-14 Brigham And Women's Hospital Rapid anesthesia emergence system using closed-loop PCO2 control
DE4100782A1 (de) * 1991-01-12 1992-07-16 Patentverwertung Dr J Haensler Waessrige ozonpraeparate, verfahren zu ihrer herstellung und ihre verwendung
US5099834A (en) * 1991-07-16 1992-03-31 Union Carbide Industrial Gases Technology Corporation Method for anesthesia
DE4132677C2 (de) * 1991-10-01 1995-08-24 Braun Melsungen Ag Flüchtige Inhalationsnarkotika enthaltende Liposomen, ihre Herstellung und Verwendung
DE4411533C1 (de) * 1994-04-02 1995-04-06 Draegerwerk Ag Anästhesiegerät
US5545396A (en) * 1994-04-08 1996-08-13 The Research Foundation Of State University Of New York Magnetic resonance imaging using hyperpolarized noble gases
DE4432378A1 (de) * 1994-09-12 1996-03-14 Bayer Ag Injizierbare liposomale Arzneizubereitungen
US5997898A (en) 1995-06-06 1999-12-07 Imarx Pharmaceutical Corp. Stabilized compositions of fluorinated amphiphiles for methods of therapeutic delivery
US5780010A (en) 1995-06-08 1998-07-14 Barnes-Jewish Hospital Method of MRI using avidin-biotin conjugated emulsions as a site specific binding system
US5807321A (en) * 1995-11-28 1998-09-15 Merit Medical System for electronically monitoring the delivery of contrast media
SE9601348D0 (sv) * 1996-04-10 1996-04-10 Pharmacia Ab Improved containers for parenteral fluids
SE9601719D0 (sv) * 1996-05-06 1996-05-06 Siemens Elema Ab Doserare för tillförsel av tillsatsgas eller vätska till andningsgas vid anestesiapparat eller ventilator
DE19709704C2 (de) * 1997-03-10 1999-11-04 Michael Georgieff Verwendung einer flüssigen Präparation von Xenon zur intravenösen Verabreichung bei Einleitung und/oder Aufrechterhaltung der Anaesthesie

Also Published As

Publication number Publication date
US6511453B2 (en) 2003-01-28
US20020052573A1 (en) 2002-05-02
EP0864329A1 (de) 1998-09-16
ATE198047T1 (de) 2000-12-15
ATE207754T1 (de) 2001-11-15
ES2162437T3 (es) 2001-12-16
ZA981953B (en) 1999-09-09
SI0966291T1 (en) 2002-04-30
EP0864329B1 (de) 2000-12-13
WO1998040084A1 (en) 1998-09-17
AP1162A (en) 2003-06-30
CN1255065A (zh) 2000-05-31
PL335444A1 (en) 2000-04-25
CA2283227A1 (en) 1998-09-17
HUP0001510A2 (hu) 2000-09-28
EE03807B1 (et) 2002-08-15
HK1028335A1 (en) 2001-02-16
IL131557A (en) 2004-06-20
HUP0001510A3 (en) 2000-12-28
ID23151A (id) 2000-03-23
US6197323B1 (en) 2001-03-06
JPH10251142A (ja) 1998-09-22
EP0966291A1 (en) 1999-12-29
DE69802268D1 (de) 2001-12-06
AU738946C (en) 2002-05-02
AU738946B2 (en) 2001-09-27
TW396040B (en) 2000-07-01
DE19709704C2 (de) 1999-11-04
CZ292767B6 (cs) 2003-12-17
NZ337534A (en) 2001-02-23
KR20000076077A (ko) 2000-12-26
HU224985B1 (en) 2006-05-29
EP0864328B1 (de) 2003-02-19
DE69802268T2 (de) 2002-05-16
RU2204397C2 (ru) 2003-05-20
ES2152608T3 (es) 2001-02-01
ZA981958B (en) 1999-09-09
CZ317399A3 (cs) 2000-01-12
AP9901630A0 (en) 1999-09-30
SK284249B6 (sk) 2004-12-01
US6328708B1 (en) 2001-12-11
CN1104901C (zh) 2003-04-09
TR199902205T2 (xx) 1999-12-21
OA11156A (en) 2003-04-22
BR9808227A (pt) 2000-05-16
NO994091L (no) 1999-10-27
KR100504287B1 (ko) 2005-07-28
NO994091D0 (no) 1999-08-24
PL189841B1 (pl) 2005-09-30
SK118799A3 (en) 2000-05-16
EP0966291B1 (en) 2001-10-31
DK0966291T3 (da) 2002-02-25
ATE232735T1 (de) 2003-03-15
PT864329E (pt) 2001-03-30
BG103712A (en) 2000-04-28
DE59702760D1 (de) 2001-01-18
AU6828698A (en) 1998-09-29
TWI241914B (en) 2005-10-21
DE19709704A1 (de) 1998-09-24
EE9900399A (et) 2000-04-17
PT966291E (pt) 2002-03-28
EP0864328A1 (de) 1998-09-16
BG64583B1 (bg) 2005-08-31
DE59709351D1 (de) 2003-03-27
WO1998040083A1 (en) 1998-09-17
GR3035553T3 (en) 2001-06-29
KR20000076117A (ko) 2000-12-26

Similar Documents

Publication Publication Date Title
DK0966291T3 (da) Medicinsk præparat, som indeholder en lipofil ædelgas
MA26549A1 (fr) Medicaments
DE69916922D1 (de) Ibuprofenhaltige Arzneizubereitung
DK0998272T3 (da) Farmaceutisk præparat til kombinationen piperidinoalkanoldekongestivum
NO20005218L (no) Farmasöytisk aerosolpreparat
ATE304351T1 (de) Arzneizubereitungen enthaltend kannabinoide
DE69833464D1 (de) Pharmazeutische Zusammensetzung, enthaltend 2,3-Diaryl-PyrazoloÄ1,5-bÜPyridazin Derivate
NO975513L (no) 3-hydroksypyridin-2-karboksylsyreamidester, fremstilling og anvendelse som legemiddel
DE59915033D1 (de) Pharmazeutische Zubereitung
ID22228A (id) Turunan-turunan 16-hidroksi-11-(disubstitusifenil)-estra-4,9-diena
NO970123D0 (no) Ny kjemisk forbindelse, dens fremstilling og anvendelse som legemiddel
TR199800703A3 (tr) Bükümhane hazirlik düzenegi.
FI971743L (fi) Liposomikoostumus, joka sisältää selegiliiniä
NO20005920L (no) Mikroemulsjons-forkonsentrater som inneholder en piperidinstoff-P-antagonist
DK1053224T3 (da) Biphenylfulfonylcyanamider, fremgangsmåde til fremstilling deraf og anvendelse deraf som lægemiddel
FI972080A0 (fi) Foerfarande foer att behaerska papperets krullning och en pappers- eller kartongmaskinlinje som tillaempar foerfarandet
MA26677A1 (fr) Medicaments antiparkinsoniens.
ITBA970043V0 (it) Sedia a struttura componibile.
ES1037533Y (es) Estructura modular simple.
SE9800251D0 (sv) A novel pharmaceutical preparation
SE9704110D0 (sv) A container, preferably for medicinal tablets
FI972453A0 (fi) Foerfarande foer att faststaella tillstaondet foer en bloeja anvaend som underskydd
FI971562A0 (fi) Anlaeggning foer att foerena en utspaedningsstroem med massastroemmen som letts fraon foerdelningsbommen i en pappersmaskin/kartongmaskin
AU2001258044A1 (en) Lipophilic medicament
FI971519A0 (fi) Sits som foerblir ren